Browse by author
Lookup NU author(s): Dr Imad Malki
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The purpose of this study was to test the hypothesis that cooperative interaction between cutaneous fatty acid-binding protein (C-FABP) and peroxisome proliferator-activated receptors (PPAR) promotes the malignant progression of human prostate cancer. The expression of C-FABP, PPARβ/δ and PPARγ was measured by western blot analysis in prostate cell lines and by immunohistochemical staining in tissue sections of benign prostatic hyperplasia (BPH) and prostatic carcinomas. The correlation between the expression of PPARs and C-FABP was assessed. The significance of increased expression of these proteins was analysed with respect to prognosis and compared with those of alternative biomarkers. The expression levels of C-FABP and PPARγ in prostate cancer cell lines and the cytoplasm and nuclei of carcinoma tissues were significantly (Student's t-test, p<0.05) higher compared to those in benign cell lines and BPH tissues. The raised expression level of C-FABP and PPARγ was significantly correlated with the increased combined Gleason scores (GS) of the carcinomas. Enhanced expression of cytoplasmic C-FABP significantly correlated with increased nuclear PPARγ (Student's t-test, p<0.005). While expression of PPARβ/δ in carcinomas did not correlate with patient outcome, the increased levels of both C-FABP and PPARγ were associated with shorter patient survival. Multivariate analysis indicated that C-FABP was independently associated with patient survival, whereas PPARγ was confounded by C-FABP in predicting patient survival. Thus, the increased C-FABP may interact with PPARγ in a coordinated mechanism to facilitate malignant progression in prostatic cancer. Both C-FABP and PPARγ are suitable as prognostic factors to predict the clinical outcome of prostatic cancer patients.
Author(s): Forootan F, Forootan S, Malki MI, Chen D, Li G, Lin K, Rudland P, Foster C, Ke Y
Publication type: Article
Publication status: Published
Journal: International Journal of Oncology
Year: 2013
Volume: 44
Issue: 1
Pages: 265-275
Print publication date: 05/11/2013
ISSN (print): 1019-6439
ISSN (electronic): 1791-2423
Publisher: Spandidos Publications
URL: http://dx.doi.org/10.3892/ijo.2013.2166
DOI: 10.3892/ijo.2013.2166
PubMed id: 24189640
Altmetrics provided by Altmetric